Target Engagement and Response to Oxytocin
Effects of Oxytocin on Social Cognition Training: Relationship to Target Engagement
Sponsor: National Institute of Mental Health (NIMH)
A PHASE4 clinical study on Schizophrenia, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 13 data snapshots since 2018. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
-
Feb 2024 — Apr 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 8 earlier versions
-
Aug 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2023 — Aug 2023 [monthly]
Recruiting PHASE4
-
Sep 2022 — Jun 2023 [monthly]
Recruiting PHASE4
-
Mar 2021 — Sep 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Dec 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Nov 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .